https://www.sciencedaily.com/news/mind_brain/caregiving/ Make informed caregiving and home health care choices for your loved ones. Read the latest research for caregivers on caregiving. en-us Sun, 19 Jul 2026 11:09:56 EDT Sun, 19 Jul 2026 11:09:56 EDT 60 https://www.sciencedaily.com/images/scidaily-logo-rss.png https://www.sciencedaily.com/news/mind_brain/caregiving/ For more science news, visit ScienceDaily. https://www.sciencedaily.com/releases/2026/07/260716023605.htm The Mediterranean diet may influence aging through tiny proteins produced inside the cell’s mitochondria. Older adults who followed the diet most closely had higher levels of humanin and SHMOOSE, which have been linked to heart and brain protection. Olive oil, fish, legumes, and fewer refined carbohydrates appeared especially important. The findings could eventually help scientists develop more personalized nutrition plans for healthy aging. Fri, 17 Jul 2026 22:24:14 EDT https://www.sciencedaily.com/releases/2026/07/260716023605.htm https://www.sciencedaily.com/releases/2026/07/260714225542.htm Researchers have discovered that a microscopic skeleton inside neurons does much more than hold cells together. It acts as a gatekeeper that controls what brain cells absorb and when they absorb it. When this protective structure weakens, neurons rapidly take in harmful proteins associated with Alzheimer's disease, suggesting that stabilizing it could become a promising new strategy for preventing brain cell damage. Wed, 15 Jul 2026 10:37:59 EDT https://www.sciencedaily.com/releases/2026/07/260714225542.htm https://www.sciencedaily.com/releases/2026/07/260712011751.htm An existing constipation drug may have an unexpected new use: helping clear the "brain fog" that often lingers after depression. In a small clinical trial, people with a history of depression who took the medication prucalopride for about a week performed better on tests of memory, attention, and thinking speed than those who received a placebo. The drug targets a serotonin receptor found in both the gut and the brain, and researchers saw no significant side effects. Wed, 15 Jul 2026 20:49:09 EDT https://www.sciencedaily.com/releases/2026/07/260712011751.htm https://www.sciencedaily.com/releases/2026/07/260711010118.htm A drug originally developed for spinal cord injury may offer a fresh approach to treating Alzheimer’s disease. In mouse studies, KCL-286 repaired dangerous DNA damage, reduced inflammation, and targeted multiple disease-related pathways instead of focusing on just amyloid or tau. Since it has already cleared an initial human safety trial, researchers believe it could move more quickly into Alzheimer’s clinical testing. Fri, 17 Jul 2026 00:19:36 EDT https://www.sciencedaily.com/releases/2026/07/260711010118.htm https://www.sciencedaily.com/releases/2026/07/260710003535.htm Researchers found that tau is essential for turning new experiences into lasting memories by helping organize the brain's memory-storing cells. The mouse study also revealed how abnormal tau may contribute to Alzheimer's by disrupting both the formation of new memories and the recall of existing ones. Sun, 12 Jul 2026 08:53:12 EDT https://www.sciencedaily.com/releases/2026/07/260710003535.htm https://www.sciencedaily.com/releases/2026/07/260710003529.htm Yale scientists discovered two neuron surface proteins that appear to help spread the toxic protein linked to Parkinson’s disease. Blocking these proteins in mice dramatically reduced disease progression, offering a potential new target for future therapies. Sat, 11 Jul 2026 22:06:14 EDT https://www.sciencedaily.com/releases/2026/07/260710003529.htm https://www.sciencedaily.com/releases/2026/06/260630020521.htm A common brain protein may be giving Alzheimer’s disease an unexpected way to spread, carrying toxic Tau proteins from damaged neurons into healthy ones. By blocking these harmful protein packages before they reach new cells, researchers believe it may one day be possible to slow the disease's relentless progression. Tue, 30 Jun 2026 03:21:06 EDT https://www.sciencedaily.com/releases/2026/06/260630020521.htm https://www.sciencedaily.com/releases/2026/06/260626125709.htm Some brains appear to fight back against Alzheimer's by helping immature brain cells survive damage instead of succumbing to it. Understanding this natural resilience could point researchers toward entirely new ways to protect memory and slow dementia. Fri, 03 Jul 2026 14:54:03 EDT https://www.sciencedaily.com/releases/2026/06/260626125709.htm https://www.sciencedaily.com/releases/2026/06/260626124701.htm Researchers have identified a previously overlooked mechanism of brain cell death that appears to play a major role in Alzheimer's disease and frontotemporal dementia. The finding could lead to new treatments aimed at slowing neuron loss by interrupting the process before cells are destroyed. Sun, 05 Jul 2026 18:58:01 EDT https://www.sciencedaily.com/releases/2026/06/260626124701.htm https://www.sciencedaily.com/releases/2026/06/260626030437.htm Using alcohol to cope with stress when young may permanently alter the brain, making it harder to adapt to challenges and increasing the risk of returning to drinking later in life. Researchers also found signs of brain damage associated with early dementia, suggesting the effects can linger long after alcohol use has stopped. Fri, 03 Jul 2026 19:43:50 EDT https://www.sciencedaily.com/releases/2026/06/260626030437.htm https://www.sciencedaily.com/releases/2026/06/260622091521.htm Scientists have discovered that a common type of stroke may have a very different cause than doctors once thought. Instead of fatty plaque clogging arteries, the strongest link was found with enlarged and damaged blood vessels deep within the brain. The finding helps explain why standard treatments like aspirin are often less effective and is driving the search for new therapies that target the brain’s tiny blood vessels directly. Fri, 03 Jul 2026 04:42:07 EDT https://www.sciencedaily.com/releases/2026/06/260622091521.htm https://www.sciencedaily.com/releases/2026/06/260622014300.htm Fish oil supplements successfully delivered omega-3s to the brain, but a two-year study found no meaningful benefits for memory, cognition, or Alzheimer’s-related brain changes. The results challenge the idea that fish oil pills can help prevent Alzheimer’s and shift attention toward overall diet and lifestyle instead. Mon, 29 Jun 2026 03:19:12 EDT https://www.sciencedaily.com/releases/2026/06/260622014300.htm https://www.sciencedaily.com/releases/2026/06/260621111113.htm Scientists at UCLA have linked long-term exposure to the pesticide chlorpyrifos with a sharply increased risk of Parkinson’s disease. People exposed to the chemical near their homes were more than twice as likely to develop the condition. Laboratory studies showed that chlorpyrifos damages dopamine neurons and interferes with the brain’s ability to remove toxic protein buildup. Sun, 28 Jun 2026 13:35:47 EDT https://www.sciencedaily.com/releases/2026/06/260621111113.htm https://www.sciencedaily.com/releases/2026/06/260620100432.htm Scientists at Baylor College of Medicine may have uncovered a promising new way to combat Alzheimer’s and Parkinson’s disease. Instead of trying to stop Tau and alpha-synuclein proteins from gathering into tiny droplets inside brain cells, the researchers found that tubulin—the protein that builds the cell’s internal transport network—can redirect these proteins away from forming toxic clumps and toward healthy, productive work. Sun, 21 Jun 2026 09:08:10 EDT https://www.sciencedaily.com/releases/2026/06/260620100432.htm https://www.sciencedaily.com/releases/2026/06/260620100428.htm A long-term Yale study is challenging one of the biggest myths about aging. Nearly half of adults over 65 improved physically, mentally, or both over time, despite the common belief that aging means constant decline. Researchers found that people with more positive attitudes about getting older were significantly more likely to show these gains. Sun, 21 Jun 2026 06:02:10 EDT https://www.sciencedaily.com/releases/2026/06/260620100428.htm https://www.sciencedaily.com/releases/2026/06/260619020506.htm A newly identified molecule called OLE helped restore the brain’s immune cells to a more protective state in Alzheimer’s models. The treatment reduced toxic plaque buildup and improved memory, raising hopes for a new therapeutic approach. Fri, 19 Jun 2026 07:47:55 EDT https://www.sciencedaily.com/releases/2026/06/260619020506.htm https://www.sciencedaily.com/releases/2026/06/260617032209.htm Scientists may have uncovered a hidden trigger behind Alzheimer’s disease. Instead of plaques being the root cause, amyloid beta appears to interfere with tau, a protein that helps keep neurons functioning properly. This disruption could set off the damage that eventually leads to the disease’s most recognizable brain changes. Thu, 18 Jun 2026 22:49:38 EDT https://www.sciencedaily.com/releases/2026/06/260617032209.htm https://www.sciencedaily.com/releases/2026/06/260616103128.htm Diabetes and dementia appear to be closely intertwined, with each condition potentially influencing the other. Problems with insulin and glucose can affect the brain’s energy supply, increase inflammation, and damage blood vessels linked to memory loss. Researchers are also finding that some popular diabetes medications may lower dementia risk. These discoveries are opening new possibilities for protecting brain health as people age. Tue, 16 Jun 2026 21:42:53 EDT https://www.sciencedaily.com/releases/2026/06/260616103128.htm https://www.sciencedaily.com/releases/2026/06/260615033835.htm A copper-based compound restored the brain’s ability to clear toxic Alzheimer’s proteins, dramatically reducing amyloid buildup and improving memory in laboratory experiments. The findings point to a potentially fast-tracked new treatment strategy because the drug has already been tested in humans for other neurological conditions. Mon, 15 Jun 2026 03:38:35 EDT https://www.sciencedaily.com/releases/2026/06/260615033835.htm https://www.sciencedaily.com/releases/2026/06/260613215430.htm A new international study finds that middle-aged Americans are lonelier, more depressed, and experiencing worse memory and health than earlier generations. Researchers say growing financial strain, weaker social supports, and chronic stress may explain why the U.S. is falling behind other wealthy nations. Sat, 13 Jun 2026 22:24:12 EDT https://www.sciencedaily.com/releases/2026/06/260613215430.htm https://www.sciencedaily.com/releases/2026/06/260612032044.htm Researchers discovered that mutations linked to blood cancers may help trigger Alzheimer’s disease by creating overly inflammatory immune cells in the brain. The unexpected finding could lead to new blood-based screening methods and potential treatments borrowed from cancer medicine. Fri, 12 Jun 2026 08:47:31 EDT https://www.sciencedaily.com/releases/2026/06/260612032044.htm https://www.sciencedaily.com/releases/2026/06/260610003044.htm A major study suggests glucosamine, a popular supplement for joint pain, could be linked to faster progression from mild cognitive impairment to Alzheimer’s disease. Researchers found a 25% higher likelihood of developing dementia among glucosamine users and uncovered biological clues that may explain why. Wed, 10 Jun 2026 01:17:56 EDT https://www.sciencedaily.com/releases/2026/06/260610003044.htm https://www.sciencedaily.com/releases/2026/06/260608040017.htm A study of more than 2,100 adults found that eating more ultra-processed foods was linked to poorer attention and slower mental processing, even among people with otherwise healthy diets. Researchers also found higher consumption was associated with increased dementia risk factors, raising concerns about the hidden cognitive costs of heavily processed foods. Tue, 09 Jun 2026 08:36:26 EDT https://www.sciencedaily.com/releases/2026/06/260608040017.htm https://www.sciencedaily.com/releases/2026/06/260608035959.htm Researchers have identified a new Alzheimer’s target and created an experimental compound that blocks a damaging process inside brain cells. In mice, the treatment slowed nerve cell loss, reduced Alzheimer’s-related changes, and even appeared to promote healthier aging. Mon, 08 Jun 2026 19:23:33 EDT https://www.sciencedaily.com/releases/2026/06/260608035959.htm https://www.sciencedaily.com/releases/2026/06/260606075901.htm Scientists have uncovered a key brain signal that helps us break old habits and adapt when circumstances suddenly change. By watching mice navigate a virtual maze, researchers found that disappointment—when an expected reward failed to appear—triggered a surge of the neurotransmitter acetylcholine, making the animals more likely to try a new strategy. When acetylcholine was blocked, the mice became less flexible and were more likely to stick with outdated choices. Mon, 08 Jun 2026 07:38:21 EDT https://www.sciencedaily.com/releases/2026/06/260606075901.htm https://www.sciencedaily.com/releases/2026/05/260530053424.htm Scientists at Scripps Research have uncovered a molecular “switch” that appears to fuel the damaging brain inflammation seen in Alzheimer’s disease. They found that a protein called STING becomes chemically altered in a way that keeps the brain’s immune system stuck in overdrive, harming the connections between nerve cells. Sun, 31 May 2026 11:30:38 EDT https://www.sciencedaily.com/releases/2026/05/260530053424.htm https://www.sciencedaily.com/releases/2026/05/260528082507.htm CBD may be doing far more than just easing pain or anxiety — new research suggests it could help fight Alzheimer’s disease by calming the brain’s runaway immune response. In experiments using Alzheimer’s mice, scientists found that inhaled CBD reduced key drivers of neuroinflammation, a damaging process increasingly linked to memory loss and brain degeneration. Thu, 28 May 2026 21:35:52 EDT https://www.sciencedaily.com/releases/2026/05/260528082507.htm https://www.sciencedaily.com/releases/2026/05/260528082505.htm Scientists at Stanford may have uncovered a hidden reason our brains decline with age. Studying the ultra-short-lived turquoise killifish, researchers discovered that the cellular machinery responsible for building proteins begins to jam and malfunction over time. Tiny structures called ribosomes start colliding and stalling while reading genetic instructions, triggering a chain reaction that leads to faulty proteins and harmful clumps linked to diseases like Alzheimer’s. Fri, 29 May 2026 10:17:40 EDT https://www.sciencedaily.com/releases/2026/05/260528082505.htm https://www.sciencedaily.com/releases/2026/05/260527023214.htm A newly identified protein called GPNMB may play a major role in helping Parkinson’s disease spread through the brain. Researchers discovered that immune cells release the protein in response to damaged neurons, creating a vicious cycle that speeds up brain cell degeneration. In early experiments, antibodies that blocked GPNMB stopped the toxic process from spreading between cells. Thu, 28 May 2026 03:12:02 EDT https://www.sciencedaily.com/releases/2026/05/260527023214.htm https://www.sciencedaily.com/releases/2026/05/260526233433.htm Scientists in Japan have created powerful new vitamin K-based compounds that may help the brain regenerate lost neurons — a breakthrough that could one day change how diseases like Alzheimer’s and Parkinson’s are treated. By combining vitamin K with components related to vitamin A, the researchers developed compounds that were about three times more effective at turning neural stem cells into neurons than natural vitamin K alone. Wed, 27 May 2026 00:02:46 EDT https://www.sciencedaily.com/releases/2026/05/260526233433.htm https://www.sciencedaily.com/releases/2026/05/260526022018.htm Researchers at Texas A&M have developed a nasal spray that appears to reverse brain aging by calming inflammation and restoring the brain’s energy systems. After just two doses, memory and cognitive function improved for months, raising hopes for future treatments targeting dementia and brain fog. Tue, 26 May 2026 09:39:35 EDT https://www.sciencedaily.com/releases/2026/05/260526022018.htm https://www.sciencedaily.com/releases/2026/05/260525000504.htm USC researchers have identified potential new drug compounds that may reduce the brain inflammation linked to Alzheimer’s disease, especially in people with the high-risk APOE4 gene. The compounds target cPLA2, an enzyme that seems to fuel harmful inflammation while also being important for normal brain activity. Tue, 26 May 2026 00:56:55 EDT https://www.sciencedaily.com/releases/2026/05/260525000504.htm https://www.sciencedaily.com/releases/2026/05/260523103950.htm For millions battling chronic nerve pain, even the softest touch can feel agonizing — but scientists may have uncovered a radically new way to stop it at the source. Researchers at Duke University found that damaged nerves can be revived by supplying them with healthy mitochondria, the tiny energy producers inside cells. Sun, 24 May 2026 07:51:53 EDT https://www.sciencedaily.com/releases/2026/05/260523103950.htm https://www.sciencedaily.com/releases/2026/05/260519224334.htm A newly identified enzyme called IDOL could become a major new target in the fight against Alzheimer’s disease. Researchers found that removing it from neurons sharply reduced amyloid plaques and improved key brain processes linked to resilience and communication between cells. The discovery may lead to future treatments that go beyond slowing Alzheimer’s — potentially helping protect the brain from further decline. Wed, 20 May 2026 08:54:32 EDT https://www.sciencedaily.com/releases/2026/05/260519224334.htm https://www.sciencedaily.com/releases/2026/05/260519224312.htm Women may be especially sensitive to the effects of common dementia risk factors, according to a new UC San Diego study of over 17,000 adults. Researchers say tailoring prevention strategies specifically for women could be key to reducing Alzheimer’s risk. Wed, 20 May 2026 09:04:32 EDT https://www.sciencedaily.com/releases/2026/05/260519224312.htm https://www.sciencedaily.com/releases/2026/05/260515234803.htm Researchers have shown for the first time that malfunctioning mitochondria — the cell’s energy generators — may directly cause cognitive decline in neurodegenerative diseases. By creating a new tool that temporarily boosts mitochondrial activity in the brain, scientists restored memory performance in mouse models of dementia. The discovery hints that energy failure inside neurons could happen before brain cells die, potentially offering a new target for future Alzheimer’s treatments. Sat, 16 May 2026 09:30:59 EDT https://www.sciencedaily.com/releases/2026/05/260515234803.htm https://www.sciencedaily.com/releases/2026/05/260515002201.htm Cannabis use among older adults is rising fast, but today’s marijuana is far more potent than many people realize — and experts warn the risks may be underestimated. Stanford Medicine specialists say modern cannabis can increase the chances of heart problems, falls, memory issues, dangerous drug interactions, and even addiction, especially for people over 65. Fri, 15 May 2026 08:18:42 EDT https://www.sciencedaily.com/releases/2026/05/260515002201.htm https://www.sciencedaily.com/releases/2026/05/260509210654.htm Scientists have uncovered a hidden “stop-scratching” signal in the nervous system that tells your brain when enough scratching is enough. The discovery centers on a molecule called TRPV4, which acts like part of an internal braking system for itch relief. In experiments involving chronic itch similar to eczema, mice missing this signal scratched less often—but when they did scratch, they couldn’t stop. Sun, 10 May 2026 03:08:07 EDT https://www.sciencedaily.com/releases/2026/05/260509210654.htm https://www.sciencedaily.com/releases/2026/05/260506225214.htm Eating eggs might do more than just start your day—it could help protect your brain. Researchers found that people 65 and older who eat eggs regularly have a significantly lower risk of developing Alzheimer’s disease, with daily or near-daily consumption linked to up to a 27% reduction. Even modest egg intake showed benefits, suggesting that small dietary changes could make a meaningful difference over time. Thu, 07 May 2026 18:22:41 EDT https://www.sciencedaily.com/releases/2026/05/260506225214.htm https://www.sciencedaily.com/releases/2026/05/260504211836.htm A new study suggests travel could be a surprisingly powerful anti-aging tool. By viewing tourism through the lens of entropy, researchers found that positive travel experiences may help the body stay balanced and resilient. Activities like exploring new places, staying active, and connecting with others can boost immunity, metabolism, and stress recovery. However, stressful or unsafe travel could reverse these benefits. Mon, 04 May 2026 22:42:07 EDT https://www.sciencedaily.com/releases/2026/05/260504211836.htm https://www.sciencedaily.com/releases/2026/05/260504075512.htm A new study suggests a surprisingly simple compound could help fight Alzheimer’s disease. Researchers found that arginine—an inexpensive amino acid already considered safe—can reduce the buildup of toxic amyloid proteins in the brain, a hallmark of the disease. In animal models, oral arginine not only lowered harmful protein deposits but also improved behavior and reduced brain inflammation. Mon, 04 May 2026 11:15:58 EDT https://www.sciencedaily.com/releases/2026/05/260504075512.htm https://www.sciencedaily.com/releases/2026/05/260502233915.htm Drugs designed to clear amyloid beta from the brain—once seen as a promising path to slowing Alzheimer’s—may not actually help patients in any meaningful way, according to a major review of over 20,000 participants. Even more concerning, they may increase the risk of brain swelling and bleeding, sometimes without obvious symptoms. Mon, 04 May 2026 01:42:05 EDT https://www.sciencedaily.com/releases/2026/05/260502233915.htm https://www.sciencedaily.com/releases/2026/05/260502013550.htm Scientists have discovered a way to help the brain clean itself of harmful Alzheimer’s plaques by activating its own support cells. By increasing a protein called Sox9, researchers were able to boost the activity of astrocytes, star shaped cells that help maintain brain health. In mice that already showed memory problems, this approach reduced plaque buildup and preserved cognitive function over time. Sat, 02 May 2026 08:57:35 EDT https://www.sciencedaily.com/releases/2026/05/260502013550.htm https://www.sciencedaily.com/releases/2026/04/260429102037.htm Researchers have identified a new potential weapon against Alzheimer’s: blocking a protein called PTP1B. In mice, this approach boosted memory and helped brain immune cells clear harmful plaque buildup. Since PTP1B is also linked to diabetes and obesity—both risk factors for Alzheimer’s—it could offer a broader treatment strategy. Thu, 30 Apr 2026 04:31:42 EDT https://www.sciencedaily.com/releases/2026/04/260429102037.htm https://www.sciencedaily.com/releases/2026/04/260426012317.htm Deep within the brain, scientists have uncovered a hidden “switch” that may decide whether pain fades away—or lingers for months or even years. Researchers found that a small, little-known region called the caudal granular insular cortex (CGIC) acts like a command center, telling the body to keep pain signals alive long after an injury has healed. In animal studies, shutting down this pathway not only prevented chronic pain from forming but could even erase it once it had taken hold. Mon, 27 Apr 2026 08:37:49 EDT https://www.sciencedaily.com/releases/2026/04/260426012317.htm https://www.sciencedaily.com/releases/2026/04/260426012303.htm Fish oil has long been praised as brain-boosting, but new research suggests the story may be more complicated. Scientists found that in people with repeated mild head injuries, a key omega-3 fatty acid in fish oil—EPA—may actually interfere with the brain’s ability to repair itself. Instead of helping recovery, it appears to weaken blood vessel stability, disrupt healing signals, and even contribute to harmful protein buildup linked to cognitive decline. Sun, 26 Apr 2026 01:57:51 EDT https://www.sciencedaily.com/releases/2026/04/260426012303.htm https://www.sciencedaily.com/releases/2026/04/260423022006.htm A rare group of adults over 80, known as SuperAgers, are rewriting what we thought was possible for the aging brain. With memory abilities comparable to people decades younger, their brains either resist or withstand the damage typically linked to Alzheimer’s disease. Decades of research reveal that their social lifestyles and unique brain biology may hold the key to preserving cognitive function. Scientists believe these insights could pave the way for new strategies to delay or even prevent dementia. Thu, 23 Apr 2026 07:46:30 EDT https://www.sciencedaily.com/releases/2026/04/260423022006.htm https://www.sciencedaily.com/releases/2026/04/260414075648.htm A lifetime of mental stimulation—like reading, writing, and learning new skills—may help protect the brain as we age. People with the highest levels of cognitive enrichment had a much lower risk of Alzheimer’s and experienced symptoms years later than those with the lowest levels. Wed, 15 Apr 2026 04:09:05 EDT https://www.sciencedaily.com/releases/2026/04/260414075648.htm https://www.sciencedaily.com/releases/2026/04/260411043048.htm Losing your sense of smell might signal Alzheimer’s far earlier than expected. Scientists found that immune cells in the brain actively destroy smell-related nerve fibers after detecting abnormal signals on their surfaces. This damage begins in early stages of the disease, well before cognitive decline. The discovery could help identify at-risk patients sooner and improve treatment timing. Sat, 11 Apr 2026 08:13:19 EDT https://www.sciencedaily.com/releases/2026/04/260411043048.htm https://www.sciencedaily.com/releases/2026/04/260409101111.htm Alzheimer’s isn’t just one problem—it’s a tangled mix of biology, aging, and overall health. That’s why drugs targeting a single factor have fallen short, even as new treatments show modest benefits. Scientists are now pushing toward multi-pronged strategies, from gene editing to brain-cell rejuvenation and gut health interventions. The goal: stop treating Alzheimer’s as one disease and start tackling it as a complex system. Fri, 10 Apr 2026 10:12:15 EDT https://www.sciencedaily.com/releases/2026/04/260409101111.htm https://www.sciencedaily.com/releases/2026/04/260408225933.htm Scientists have uncovered a surprising new player in Alzheimer’s disease: a protein called CSE that helps produce tiny amounts of hydrogen sulfide gas in the brain. In experiments with genetically engineered mice, removing this protein led to memory loss, brain damage, and other hallmarks of Alzheimer’s, including weakened blood-brain barriers and reduced formation of new neurons. The findings suggest that this “rotten egg” gas, when carefully regulated, may actually protect brain cells and support memory. Wed, 08 Apr 2026 22:59:33 EDT https://www.sciencedaily.com/releases/2026/04/260408225933.htm https://www.sciencedaily.com/releases/2026/04/260406192922.htm Scientists at Oregon State University have captured something researchers have long struggled to see: the real-time chemical interactions that help drive Alzheimer’s disease. By watching how metal ions—especially copper—trigger harmful protein clumping in the brain, the team uncovered a clearer picture of how the disease develops at a molecular level. Tue, 07 Apr 2026 07:37:31 EDT https://www.sciencedaily.com/releases/2026/04/260406192922.htm https://www.sciencedaily.com/releases/2026/04/260406192913.htm A single week of intensive meditation and mind-body practices led to measurable changes across the brain and body. Researchers observed improved brain efficiency, boosted immune signaling, and increased natural pain relief chemicals in participants’ blood. The effects even promoted neuron growth and stronger brain connectivity. Surprisingly, the experience mirrored psychedelic-like brain states—without any drugs involved. Tue, 07 Apr 2026 03:56:04 EDT https://www.sciencedaily.com/releases/2026/04/260406192913.htm https://www.sciencedaily.com/releases/2026/04/260401071931.htm A surprising new study suggests that genetics may change how diet affects brain health—especially when it comes to Alzheimer’s risk. Researchers found that older adults carrying high-risk APOE gene variants didn’t show the expected cognitive decline if they ate relatively high amounts of meat. In fact, those with these genes who consumed the most meat had slower cognitive decline and lower dementia risk, challenging conventional dietary advice. Thu, 02 Apr 2026 13:54:07 EDT https://www.sciencedaily.com/releases/2026/04/260401071931.htm https://www.sciencedaily.com/releases/2026/03/260328043558.htm Scientists have developed a new gene therapy that quiets pain at its source in the brain—without the addictive risks of opioids. Using AI to map how pain is processed, they created a targeted “off switch” that mimics morphine’s benefits but skips its dangerous side effects. In early tests, it delivered lasting relief without affecting normal sensations. The discovery could mark a major step toward safer, non-addictive pain treatments. Sat, 28 Mar 2026 20:57:04 EDT https://www.sciencedaily.com/releases/2026/03/260328043558.htm https://www.sciencedaily.com/releases/2026/03/260328043556.htm After a stroke, the brain may do something surprisingly hopeful—it can “refresh” parts of itself. Researchers analyzing brain scans from over 500 stroke survivors found that while the damaged side of the brain appears to age faster, the opposite, unaffected side can actually look younger. This unexpected shift seems to reflect the brain’s effort to rewire itself, strengthening healthy regions to compensate for lost function. Sun, 29 Mar 2026 06:34:17 EDT https://www.sciencedaily.com/releases/2026/03/260328043556.htm https://www.sciencedaily.com/releases/2026/03/260325005920.htm Researchers have identified a crucial ion channel, TMEM175, that acts like an overflow valve in the cell’s recycling system. It regulates acidity inside lysosomes, ensuring they function properly. When TMEM175 is faulty, toxic buildup can occur, contributing to diseases like Parkinson’s. This breakthrough reveals a promising new target for future therapies. Thu, 26 Mar 2026 07:35:07 EDT https://www.sciencedaily.com/releases/2026/03/260325005920.htm https://www.sciencedaily.com/releases/2026/03/260324230102.htm Balance problems in aging and Parkinson’s may come from the body working too hard, not too little. Scientists found that the brain and muscles become overactive during even minor disturbances, yet this actually weakens balance recovery. At the same time, muscles can stiffen against each other, making movement less stable. This unexpected pattern could help predict who is more likely to fall. Wed, 25 Mar 2026 00:29:12 EDT https://www.sciencedaily.com/releases/2026/03/260324230102.htm https://www.sciencedaily.com/releases/2026/03/260323005526.htm Scientists have uncovered a hidden “death switch” in the brain that may be driving Alzheimer’s disease—and even found a way to turn it off in mice. The culprit is a toxic pairing of two proteins that, when combined, triggers the destruction of brain cells and fuels memory loss. By using a new compound to break apart this deadly duo, researchers were able to slow disease progression, protect brain cells, and even reduce hallmark amyloid buildup. Mon, 23 Mar 2026 05:34:10 EDT https://www.sciencedaily.com/releases/2026/03/260323005526.htm https://www.sciencedaily.com/releases/2026/03/260317064457.htm A key Alzheimer’s drug has finally revealed its secret. Researchers discovered that lecanemab works by activating the brain’s immune cells—but only through a specific part of the antibody called the Fc fragment. This piece acts like a trigger, prompting microglia to clear harmful amyloid plaques. The finding could reshape how future Alzheimer’s therapies are designed. Tue, 17 Mar 2026 07:44:52 EDT https://www.sciencedaily.com/releases/2026/03/260317064457.htm